Sidney Kimmel Comprehensive Cancer Center - 4F Second Medical Building — Baltimore, Maryland

Sidney Kimmel Comprehensive Cancer Center - 4F Second Medical Building is a clinical research site located in Baltimore, Maryland, United States 21231.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Sidney Kimmel Comprehensive Cancer Center - 4F Second Medical Building has participated in 1 clinical trials.

Therapeutic areas: Advanced NSCLC.

Sponsors: Regeneron Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Baltimore

Browse all research sites in Maryland · View every site in Baltimore

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sidney Kimmel Comprehensive Cancer Center - 4F Second Medical Building?

Sidney Kimmel Comprehensive Cancer Center - 4F Second Medical Building has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sidney Kimmel Comprehensive Cancer Center - 4F Second Medical Building conducted?

Sidney Kimmel Comprehensive Cancer Center - 4F Second Medical Building has 1 clinical trials on record. Their work covers Advanced NSCLC.

Is Sidney Kimmel Comprehensive Cancer Center - 4F Second Medical Building accredited by Crixeo Clinical Trials?

Sidney Kimmel Comprehensive Cancer Center - 4F Second Medical Building has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sidney Kimmel Comprehensive Cancer Center - 4F Second Medical Building?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.